Company Sector
CNS
CNS refers to central nervous system diseases such as depression, schizophrenia, epilepsy, Alzheimer's disease, Parkinson's disease, and other neurological or psychiatric conditions. Companies on this page are grouped by their exposure to brain and nervous system therapeutics.
Why watch CNS
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest CNS news
The latest feed items from companies currently grouped under CNS.
- 01
- 02
TSHATaysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Source: Taysha Gene Therapies
- 03
NERVMinerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates
Source: Minerva Neuroscience
- 04
BIIBBiogen Completes Acquisition of RayThera Inc.
Source: Biogen
- 05
CGTXCognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
Source: Cognition Therapeutics
- 06
ECORelectroCore Announces Second Quarter 2026 Financial Results
Source: electroCore
- 07
- 08
DNLIDenali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Source: Denali Therapeutics
- 09
VYGRVoyager Reports Second Quarter 2026 Financial and Operating Results
Source: Voyager Therapeutics
- 10
VTGNVistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
Source: Vistagen Therapeutics, Inc.
- 11
HRMYHarmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium
Source: Harmony Biosciences
- 12
- 13
PRAXPraxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Source: Praxis Precision Medicines
- 14
ATHEAlterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
Source: Alterity Therapeutics
- 15
- 16
XERSXeris Biopharma Reports Second Quarter 2026 Financial Results
Source: Xeris Pharmaceuticals
- 17
ABOSAcumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026
Source: Acumen Pharmaceuticals
- 18
TNXPTonix Pharmaceuticals to Participate in Upcoming Investor Conferences
Source: Tonix Pharmaceuticals
- 19
ACIUAC Immune First Half 2026 Financial and Corporate Update
Source: AC Immune
- 20
PRAXPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Praxis Precision Medicines
Companies in CNS
92 companies tagged with CNS.
Frequently Asked Questions
What does the CNS sector include?
CNS refers to central nervous system diseases such as depression, schizophrenia, epilepsy, Alzheimer's disease, Parkinson's disease, and other neurological or psychiatric conditions. Companies on this page are grouped by their exposure to brain and nervous system therapeutics.
How many companies are currently tagged with CNS?
92 companies are currently grouped under CNS on BioPharmSignal.
Which companies are most visible in the CNS group right now?
ABBV, ABVC, ACIU, ACAD are among the companies currently shown on this sector page.
How can I watch news for CNS?
Use the Watch button on this page to subscribe to CNS headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for CNS?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in CNS.